The Impact of Perceived Adverse Effects on Medication Changes in Heart Failure Patients

Journal of Cardiac Failure

Volumn 16, Issue 2, 2010, Pages

  De Smedt, Ruth H E ^a   Jaarsma, Tiny ^a   Haaijer Ruskamp, Flora M ^a   Denig, Petra ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIAC GLYCOSIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LOOP DIURETIC AGENT; POTASSIUM SPARING DIURETIC AGENT;

AGED; ARTICLE; COHORT ANALYSIS; COUGHING; DIARRHEA; DIZZINESS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GOUT; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT;

EID: 75149123377     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2009.09.006     Document Type: Article

References (28)

1. Dickstein K., Cohen-Solal A., Filippatos G., McMurray J.J., Ponikowski P., Poole-Wilson P.A., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 10 (2008) 933-989
2. Heart Failure Society Of America. Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail 12 (2006) 10-38
3. De Smedt R.H., Denig P., Haaijer-Ruskamp F.M., and Jaarsma T. Perceived medication adverse effects and coping strategies reported by chronic heart failure patients. Int J Clin Pract 63 (2009) 233-242
4. Richard C., and Lussier M.T. Measuring patient and physician participation in exchanges on medications: dialogue ratio, preponderance of initiative, and dialogical roles. Patient Educ Couns 65 (2007) 329-341
5. Gandhi T.K., Burstin H.R., Cook E.F., Puopolo A.L., Haas J.S., Brennan T.A., et al. Drug complications in outpatients. J Gen Intern Med 15 (2000) 149-154
6. van der Wal M.H., Jaarsma T., and van Veldhuisen D.J. Non-compliance in patients with heart failure; how can we manage it?. Eur J Heart Fail 7 (2005) 5-17
7. van der Wal M.H., and Jaarsma T. Adherence in heart failure in the elderly: problem and possible solutions. Int J Cardiol 125 (2008) 203-208
8. Gandhi T.K., Weingart S.N., Borus J., Seger A.C., Peterson J., Burdick E., et al. Adverse drug events in ambulatory care. N Engl J Med 348 (2003) 1556-1564
9. Forster A.J., Murff H.J., Peterson J.F., Gandhi T.K., and Bates D.W. Adverse drug events occurring following hospital discharge. J Gen Intern Med 20 (2005) 317-323
10. Jaarsma T., van der Wal M.H., Hogenhuis J., Lesman I., Luttik M.L., Veeger N.J., et al. Design and methodology of the COACH study: a multicenter randomised Coordinating study evaluating Outcomes of Advising and Counselling in Heart failure. Eur J Heart Fail 6 (2004) 227-233
11. Jaarsma T., van der Wal M.H., Lesman-Leegte I., Luttik M.L., Hogenhuis J., Veeger N.J., et al. Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH). Arch Intern Med 168 (2008) 316-324
12. College voor zorgverzekeringen. Farmacotherapeutisch Kompas 2007. Utrecht (NL). 2007.
13. Altman D.G., and Bland J.M. Interaction revisited: the difference between two estimates. BMJ 326 (2009) 219
14. Bekelman D.B., Havranek E.P., Becker D.M., Kutner J.S., Peterson P.N., Wittstein I.S., et al. Symptoms, depression, and quality of life in patients with heart failure. J Card Fail 13 (2007) 643-648
15. Zambroski C.H., Moser D.K., Bhat G., and Ziegler C. Impact of symptom prevalence and symptom burden on quality of life in patients with heart failure. Eur J Cardiovasc Nurs 4 (2005) 198-206
16. Weingart S.N., Gandhi T.K., Seger A.C., Seger D.L., Borus J., Burdick E., et al. Patient-reported medication symptoms in primary care. Arch Intern Med 165 (2005) 234-240
17. Jarernsiripornkul N., Krska J., Capps P.A., Richards R.M., and Lee A. Patient reporting of potential adverse drug reactions: a methodological study. Br J Clin Pharmacol 53 (2002) 318-325
18. Davis R.E., Koutantji M., and Vincent C.A. How willing are patients to question healthcare staff on issues related to the quality and safety of their healthcare? An exploratory study. Qual Saf Health Care 17 (2008) 90-96
19. Laurant M.G.H., Hermens R.P.M.G., Braspenning J.C.C., Akkermans R.P., Sibbald B., and Grol R.P.T.M. An overview of patients' preference for, and satisfaction with, care provided by general practitioners and nurse practitioners. J Clin Nurs 17 (2008) 2690-2698
20. Lampela P., Hartikainen S., Sulkava R., and Huupponen R. Adverse drug effects in elderly people-a disparity between clinical examination and adverse effects self-reported by the patient. Eur J Clin Pharmacol 63 (2007) 509-515
21. Jarernsiripornkul N., Kakaew W., Loalukkana W., and Krska J. Adverse drug reaction monitoring: comparing doctor and patient reporting for new drugs. Pharmacoepidemiol Drug Saf 18 (2009) 240-245
22. Cosentino M., Leoni O., Oria C., Michielotto D., Massimo E., Lecchini S., et al. Hospital-based survey of doctors' attitudes to adverse drug reactions and perception of drug-related risk for adverse reaction occurrence. Pharmacoepidemiol Drug Saf 8 (1999) S27-S35
23. Golomb B.A., McGraw J.J., Evans M.A., and Dimsdale J.E. Physician response to patient reports of adverse drug effects: implications for patient-targeted adverse effect surveillance. Drug Saf 30 (2007) 669-675
24. Rogers A., Addington-Hall J.M., McCoy A.S., Edmonds P.M., Abery A.J., Coats A.J., et al. A qualitative study of chronic heart failure patients' understanding of their symptoms and drug therapy. Eur J Heart Fail 4 (2002) 283-287
25. Stevenson F.A., Barry C.A., Britten N., Barber N., and Bradley C.P. Doctor-patient communication about drugs: the evidence for shared decision making. Soc Sci Med 50 (2000) 829-840
26. Dusing R., Weisser B., Mengden T., and Vetter H. Changes in antihypertensive therapy-the role of adverse effects and compliance. Blood Press 7 (1998) 313-315
27. Ziegler D.K., Mosier M.C., Buenaver M., and Okuyemi K. How much information about adverse effects of medication do patients want from physicians?. Arch Intern Med 161 (2001) 706-713
28. Tangiisuran B., Wright J., Van der C.T., and Rajkumar C. Adverse drug reactions in elderly: challenges in identification and improving preventative strategies. Age Ageing 38 (2009) 358-359